CAS RN: 771-15-3
2-BROMO-NAPHTHALEN-1-OL
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20251231
1g / 10g / 25g / 100g
Confirm by inquiry
Shanghai, Shandong 5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 771-15-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
>97%
0
Out of Stock
Shenzhen
Inquiry
771-15-3 / 2-bromonaphthalen-1-ol
Standard CAS: 771-15-3
Multi CAS: No
Basic Information
copy
CAS
771-15-3 copy
Multi CAS
No copy
Molecular Formula
C10H7BRO copy
Molecular Weight
223.070000 copy
Exact Mass
221.968030 copy
InChI
InChI=1S/C10H7BrO/c11-9-6-5-7-3-1-2-4-8(7)10(9)12/h1-6,12H copy
InChIKey
LOHOSHDZQVKDPS-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
12 copy
Aromatic heavy atom count
10 copy
H-bond acceptors
1 copy
H-bond donors
1 copy
Molar refractivity
53.31 copy
TPSA
20.23 copy
LogP / Solubility
WLOGP
3.31 copy
MLOGP
2.91 copy
XLogP3
3.2 copy
Consensus LogP
3.14 copy
Log S (ESOL)
-3.92 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.78 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.86 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.73 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy